Department of Surgery, Mayo Clinic, Rochester, MN; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
Department of Surgery, Mayo Clinic, Rochester, MN.
Mayo Clin Proc. 2018 Apr;93(4):429-435. doi: 10.1016/j.mayocp.2017.11.023. Epub 2018 Feb 10.
To identify factors predicting positive margins at lumpectomy prompting intraoperative reexcision in patients with breast cancer treated at a large referral center.
We reviewed all breast cancer lumpectomy cases managed at our institution from January 1, 2012, through December 31, 2013. Associations between rates of positive margin and patient and tumor factors were assessed using χ tests and univariate and adjusted multivariate logistic regression, stratified by ductal carcinoma in situ (DCIS) or invasive cancer.
We identified 382 patients who underwent lumpectomy for definitive surgical resection of breast cancer, 102 for DCIS and 280 for invasive cancer. Overall, 234 patients (61.3%) required intraoperative reexcision for positive margins. The reexcision rate was higher in patients with DCIS than in those with invasive disease (78.4% [80 of 102] vs 56.4% [158 of 280]; univariate odds ratio, 2.80; 95% CI, 1.66-4.76; P<.001). Positive margin rates did not vary by patient age, surgeon, estrogen receptor, progesterone receptor, or ERBB2 status of the tumor. Among the 280 cases of invasive breast cancer, the only factor independently associated with lower odds of margin positivity was seed localization vs no localization (P=.03).
Ductal carcinoma in situ was associated with a higher rate of positive margins at lumpectomy than invasive breast cancer on univariate analysis. Within invasive disease, seed localization was associated with lower rates of margin positivity.
确定在大型转诊中心治疗的乳腺癌患者中,保乳手术后切缘阳性预测因素,以促使术中再次切除。
我们回顾了 2012 年 1 月 1 日至 2013 年 12 月 31 日期间在我院接受保乳手术的所有乳腺癌病例。使用 χ 检验和单变量及调整后的多变量逻辑回归评估切缘阳性率与患者和肿瘤因素之间的关系,并按导管原位癌 (DCIS) 或浸润性癌分层。
我们确定了 382 例接受保乳术治疗乳腺癌的患者,其中 102 例为 DCIS,280 例为浸润性癌。总体而言,234 例 (61.3%)患者因切缘阳性需要术中再次切除。DCIS 患者的再次切除率高于浸润性疾病患者 (78.4% [80/102] vs 56.4% [158/280];单变量优势比,2.80;95%CI,1.66-4.76;P<.001)。切缘阳性率与患者年龄、外科医生、雌激素受体、孕激素受体或肿瘤 ERBB2 状态无关。在 280 例浸润性乳腺癌病例中,唯一与切缘阳性率较低独立相关的因素是种子定位与无定位 (P=.03)。
在单变量分析中,DCIS 与保乳手术后切缘阳性率高于浸润性乳腺癌相关。在浸润性疾病中,种子定位与较低的切缘阳性率相关。